Portolan Capital Management, LLC
Position in CADL — Candel Therapeutics, Inc.
CIK 1350290
BOSTON, MA
Position in CADL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$35,951,099
+$21,768,907 QoQ
Shares Held
3,490,398
+20.6% QoQ
Ownership
4.56%
of shares outstanding
% of Portfolio
1.35%
of 13F equity value
Holder Rank
#6
of 138 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CADL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Portolan Capital Management, LLC holds $46,223,505 across 3 Biotechnology names. CADL ranks #1 (77.8% of the industry book) .
All Filings in CADL
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $35,951,099 | 3,490,398 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $14,182,192 | 2,894,325 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $9,578,823 | 1,695,367 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $7,059,124 | 1,384,142 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $8,205,943 | 1,621,728 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $4,978,689 | 881,184 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $6,542,506 | 753,745 | Shares | Sole | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||